Literature DB >> 12397638

Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors.

Annica Jacobson1, Mehdi Rahmanian, Kristofer Rubin, Paraskevi Heldin.   

Abstract

Advanced colorectal cancers are often associated with elevated amounts of hyaluronan. To investigate the importance of hyaluronan in colon carcinoma tumor progression, we have expressed by stable transfection hyaluronan synthase 2 (Has2) and hyaluronidase 1 (Hyal1) in the rat colon carcinoma cell line, PROb. We found that hyaluronan overproduction led to a higher growth rate of tumor cells in vitro, and to a faster development of transplantable tumors in syngeneic rats, compared to the mock-transfectants. Has2 transfected PROb cells gave rise to tumors that were significantly less vascularized, but had a significantly larger viable tumor fraction compared to tumors generated from mock-transfectants. In contrast, Hyal1 overexpression suppressed the growth rate of tumor cells both in vitro and in vivo. Moreover, tumors derived from Hyal1-transfected cells had a significantly larger necrotic area than tumors derived from mock- and Has2-transfectants. Our study demonstrates that Has2 overproduction promotes tumorigenicity, whereas Hyal1 overexpression suppresses tumorigenicity in an experimental model for colon carcinoma. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12397638     DOI: 10.1002/ijc.10683

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

Review 1.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

Authors:  Ki Young Choi; Gurusamy Saravanakumar; Jae Hyung Park; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-20       Impact factor: 5.268

2.  Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1).

Authors:  Berit Bernert; Helena Porsch; Paraskevi Heldin
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

Review 3.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

4.  Glycoblotting-based high throughput protocol for the structural characterization of hyaluronan degradation products during enzymatic fragmentation.

Authors:  Takayuki Furukawa; Misaki Arai; Fayna Garcia-Martin; Maho Amano; Hiroshi Hinou; Shin-Ichiro Nishimura
Journal:  Glycoconj J       Date:  2012-05-26       Impact factor: 2.916

5.  Cytokines and growth factors stimulate hyaluronan production: role of hyaluronan in epithelial to mesenchymal-like transition in non-small cell lung cancer.

Authors:  Geraldine Chow; Jordi Tauler; James L Mulshine
Journal:  J Biomed Biotechnol       Date:  2010-06-30

6.  Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma.

Authors:  Timo K Nykopp; Kirsi Rilla; Markku I Tammi; Raija H Tammi; Reijo Sironen; Kirsi Hämäläinen; Veli-Matti Kosma; Seppo Heinonen; Maarit Anttila
Journal:  BMC Cancer       Date:  2010-09-27       Impact factor: 4.430

Review 7.  Emerging roles for hyaluronidase in cancer metastasis and therapy.

Authors:  Caitlin O McAtee; Joseph J Barycki; Melanie A Simpson
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

Review 8.  Hyalurondiase: both a tumor promoter and suppressor.

Authors:  Vinata B Lokeshwar; Marie G Selzer
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

Review 9.  Hyaluronan and hyaluronidase in genitourinary tumors.

Authors:  Melanie A Simpson; Vinata B Lokeshwar
Journal:  Front Biosci       Date:  2008-05-01

10.  Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer.

Authors:  Yoichi Yamada; Naoki Itano; Hisashi Narimatsu; Takashi Kudo; Kyoei Morozumi; Setsuo Hirohashi; Atsushi Ochiai; Minoru Ueda; Koji Kimata
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.